This inventor holds 6 USPTO granted patents. Top assignees: Behringwerke Aktiengesellschaft, Laboratoires Hoechst S/a, Adir Et Compagnie. Active years: 1996-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 340 
2 out of 7 
1 out of 368 
Years Active: 1996-2000
Title: Francedillaois Tillequin: A Pioneer in Pharmaceutical Innovations
Introduction
Francedillaois Tillequin is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs. With a total of six patents to his name, Tillequin's work has had a lasting impact on the industry.
Latest Patents
Tillequin's latest patents focus on the preparation and use of glycosyl-spacer-drug compounds as pharmaceuticals. These prodrugs are designed to enhance the efficacy and delivery of therapeutic agents. His innovative approach to prodrugs has opened new avenues for pharmaceutical applications.
Career Highlights
Throughout his career, Tillequin has worked with prominent companies such as Behringwerke Aktiengesellschaft and Laboratoires Hoechst S.A. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Tillequin has collaborated with esteemed colleagues, including Michel Koch and Klaus Bosslet. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Francedillaois Tillequin's contributions to the pharmaceutical field through his innovative patents and collaborations highlight his role as a key figure in advancing drug development. His work continues to influence the industry and improve therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile